Therefore, the prognostic model constructed based on the eight screened FAM genes might be able to guide the application of immunotherapy for colon cancer patients, and these FAM genes could be potential targets for immunotherapy to reverse the fate of immune cells in the TME. This evidence concerns the gene USP9X and colonic neoplasm.